VNRX · AMEX
VolitionRX (VNRX) Stock Price & Fundamentals
VolitionRX (VNRX) closed at $530.73 on Oct 9, 2026, down 1.14% from the previous close of $536.86.
Share price, past year
1Y +12.70%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $530.73 |
| Sep 30, 2026 | $536.62 |
| Aug 31, 2026 | $537.66 |
| Jul 31, 2026 | $523.03 |
| Jun 30, 2026 | $506.80 |
| May 29, 2026 | $520.00 |
| Apr 30, 2026 | $519.50 |
| Mar 31, 2026 | $526.50 |
| Feb 27, 2026 | $513.15 |
| Jan 30, 2026 | $533.82 |
| Dec 31, 2025 | $494.33 |
| Nov 28, 2025 | $488.28 |
| Oct 31, 2025 | $485.85 |
Key statistics
- Market cap
- $6.39B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $2.46M
- Net income (TTM)
- −$25.64M
- Shares outstanding
- 12M
- Dividend yield
- —
- 52-week range
- $462.74 – $554.71
VolitionRX's market cap is $6.39B, based on a share price of $530.73 and 12M shares outstanding as of Jun 30, 2026.
Financials
VolitionRX reported revenue of $1.73M for fiscal 2025, up 40.04% from fiscal 2024.
VolitionRX reported a net loss of $23.36M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 9 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.73M | +40.0% | −$23.36M | −1,352.2% | — | −$19.77M |
| FY2024ended Dec 31, 2024 | $1.23M | +59.1% | −$26.97M | −2,186.3% | −$0.31 | −$26.17M |
| FY2023ended Dec 31, 2023 | $775.30K | +153.0% | −$35.68M | −4,601.7% | −$0.50 | −$19.15M |
| FY2022ended Dec 31, 2022 | $306.39K | +240.3% | −$30.60M | −9,986.7% | — | −$16.85M |
| FY2021ended Dec 31, 2021 | $90.04K | +570.3% | −$26.99M | −29,977.0% | −$0.51 | −$21.83M |
| FY2020ended Dec 31, 2020 | $13.43K | −21.4% | −$20.40M | −151,859.6% | −$0.45 | −$18.41M |
| FY2019ended Dec 31, 2019 | $17.10K | +15.6% | −$16.10M | −94,168.6% | −$0.41 | −$13.25M |
| FY2014ended Dec 31, 2014 | $14.79K | −73.1% | — | — | −$0.61 | — |
| FY2012ended Dec 31, 2012 | $54.97K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $398.66K | −$7.33M | −$0.85 |
| Q1 FY2026ended Mar 31, 2026 | $985.08K | −$6.66M | −$0.97 |
| Q4 FY2025ended Dec 31, 2025 | $447.03K | −$6.27M | — |
| Q3 FY2025ended Sep 30, 2025 | $627.28K | −$5.38M | −$0.05 |
| Q2 FY2025ended Jun 30, 2025 | $406.69K | −$6.28M | −$1.22 |
| Q1 FY2025ended Mar 31, 2025 | $246.39K | −$5.42M | −$1.12 |
| Q4 FY2024ended Dec 31, 2024 | $191.66K | −$5.79M | −$0.06 |
| Q3 FY2024ended Sep 30, 2024 | $474.52K | −$5.82M | −$0.07 |
Company profile
- Name
- VolitionRX Limited
- Ticker
- VNRX
- Exchange
- AMEX
- Industry (SEC SIC)
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- 1489 West Warm Springs Road, Suite 110, Henderson, NV 89014
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000093314
Recent SEC filings
- Sep 25, 2026
- Sep 15, 2026
- Sep 14, 2026
- Sep 2, 2026
- Sep 2, 2026
- Aug 24, 2026
- Aug 13, 2026
- Aug 13, 2026
Frequently asked questions
What is VolitionRX's stock price?
VolitionRX (VNRX) closed at $530.73 on Oct 9, 2026, down 1.14% from the previous close of $536.86.
What is VolitionRX's market cap?
VolitionRX's market cap is $6.39B, based on a share price of $530.73 and 12M shares outstanding as of Jun 30, 2026.
How much revenue does VolitionRX make?
VolitionRX reported revenue of $1.73M for fiscal 2025, up 40.04% from fiscal 2024.
Does VolitionRX pay a dividend?
VolitionRX's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from VolitionRX Limited's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures